Scarica l'app Stockscreener
0.40
1.48%
-0.006
Dopo l'orario di chiusura:
.41
0.010
+2.50%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché JAGX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.406
Aprire:
$0.3885
Volume 24 ore:
197.17K
Relative Volume:
0.05
Capitalizzazione di mercato:
$4.97M
Reddito:
$11.79M
Utile/perdita netta:
$-41.04M
Rapporto P/E:
-0.0118
EPS:
-33.9843
Flusso di cassa netto:
$-26.29M
1 W Prestazione:
+1.96%
1M Prestazione:
-50.06%
6M Prestazione:
-80.09%
1 anno Prestazione:
-90.58%
Intervallo 1D:
$0.3701
$0.4098
Intervallo di 1 settimana:
$0.313
$0.48
Portata 52W:
$0.313
$14.07
Jaguar Health Inc Stock (JAGX) Company Profile
Nome
Jaguar Health Inc
Settore
Industria
Telefono
415-371-8300
Indirizzo
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Compare JAGX vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
JAGX
Jaguar Health Inc
|
0.40 | 4.97M | 11.79M | -41.04M | -26.29M | -33.98 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-07-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-07-11 | Iniziato | Rodman & Renshaw | Buy |
Jaguar Health Inc Borsa (JAGX) Ultime notizie
Rate Cut: Will Jaguar Health Inc benefit from AI trends2026 Trading Volume Trends & Low Risk Entry Point Tips - baoquankhu1.vn
Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress - accessnewswire.com
Jaguar Health, Inc. (JAGX) Stock Price, News, Quote & History - Yahoo! Finance Canada
JAGX Q4'25 Earnings: EPS estimate is (4.26) USD - TradingView
Children needing IV nutrition cut support 12%-37% in crofelemer study - Stock Titan
JAGX Stock Chart | JAGUAR HEALTH INC (NASDAQ:JAGX) - ChartMill
Jaguar Health Delays Annual Form 10-K Filing - TipRanks
Jaguar Health (NASDAQ: JAGX) notifies SEC of late 10-K; will file within 15 days - Stock Titan
JAGX Stock Price, Quote & Chart | JAGUAR HEALTH INC (NASDAQ:JAGX) - ChartMill
Jaguar Health Inc. (JAGX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
JAGX Q4'25 Earnings: revenue estimate is 4.21M USD - TradingView
Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates - Central New Jersey News
Article About Groundbreaking Results from Study of Jaguar Health's Crofelemer for Treatment of Intestinal Failure Featured in United Arab Emirates Healthcare Publication - burlingtonfreepress.com
Published on: 2026-03-29 01:23:24 - baoquankhu1.vn
Jaguar Health Inc Stock: Commercial-Stage Pharma Targeting Gastrointestinal Disorders in Humans and - AD HOC NEWS
Entry Recap: Is Jaguar Health Inc undervalued by DCF analysisAnalyst Upgrade & Low Risk High Reward Ideas - baoquankhu1.vn
Jaguar Health Inc stock faces extreme dilution risk as proxy seeks massive share increase and dual r - AD HOC NEWS
Jaguar Health (NASDAQ: JAGX) eyes major reverse splits and note-for-equity issuance - Stock Titan
If You Invested $1,000 in Jaguar Health Inc (JAGX) - Stock Titan
Will Jaguar Health Inc outperform the market in YEAR2026 Risk Factors & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Should value investors consider Jaguar Health Inc2026 Dividend Review & AI Based Trade Execution Alerts - baoquankhu1.vn
Jaguar Health Announces Online Availability of a Presentation on Short Bowel Syndrome (SBS) by Dr. Mohamad Miqdady at Elite Ped-GI Congress in Abu Dhabi - accessnewswire.com
Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts - Green Bay Press-Gazette
JAGX Forecast, Price Target & Analyst Ratings | JAGUAR HEALTH INC (NASDAQ:JAGX) - ChartMill
FDA Feedback Supports Extension Phase for Jaguar Health's Clinical Trial of Crofelemer for Treatment of Microvillus Inclusion Disease (MVID) - Bitget
Jaguar Health (JAGX) Advances Pediatric Crofelemer Study - gurufocus.com
FDA backs longer crofelemer trial for lethal ultra-rare childhood MVID - Stock Titan
Published on: 2026-03-19 06:11:46 - baoquankhu1.vn
Earnings Recap: Is Jaguar Health Inc stock a top performer YTDDay Trade & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Jaguar Health unit begins coca extract study for weight management By Investing.com - Investing.com Australia
Jaguar Health (JAGX) Launches Preclinical Study on Coca Leaf Ext - GuruFocus
Jaguar Health unit begins coca extract study for weight management - Investing.com
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression - accessnewswire.com
Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression - FinanzNachrichten.de
Jaguar Health, Inc. Trade Ideas — GETTEX:1JA0 - TradingView
Performance Recap: Will Jaguar Health Inc benefit from AI trends2026 Rallies & Real-Time Buy Zone Alerts - baoquankhu1.vn
Jaguar Health (NASDAQ: JAGX) asks shareholders to OK reverse splits, large potential dilution - Stock Titan
Jaguar Health at Life Sciences Forum: Strategic Shift to Rare Diseases - Investing.com
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Sheboygan Press
Director John Micek granted stock options and RSUs at Jaguar Health (JAGX) - Stock Titan
Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts - Bradenton Herald
User - The Chronicle-Journal
Published on: 2026-03-11 18:03:23 - baoquankhu1.vn
Jaguar Health CEO to outline 'near-term catalysts' at virtual investor forum - Stock Titan
Jaguar Health, Inc. Enters Global Amendment Agreements and Security Agreement – March 2026 8-K Filing Details - Minichart
Jaguar Health (JAGX) Restructures Debt and Reduces Royalties - GuruFocus
According to the latest SEC filing, Jaguar Health Inc (NASDAQ: JAGX) has completed the amendment to the Uptown 2020 royalty interest agreement. - Bitget
Jaguar Animal Health Restructures Debt and Royalty Agreements - TipRanks
Jaguar Health Strengthens Company's Balance Sheet by Restructuring and Reducing Royalty and Debt Obligations and Extinguishing Warrants - ACCESS Newswire
Jaguar Health Extends Debt, Defers Royalty Payments; Terminates 48,211-Share Warrants - TradingView
Debt extensions and warrant termination reshape Jaguar Health (NASDAQ: JAGX) - Stock Titan
Jaguar Health Inc Azioni (JAGX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):